Mary Cushman: Circulating Biomarkers and New Risk Score Enhance Stroke Prediction in AFib
Mary Cushman, Hematologist, University Distinguished Professor and Vice Chair for Emerging Researchers at UVM Department of Medicine, shared on X:
”New risk calculator for stroke prediction in Atrial Fibrillation
Two REGARDS Study manuscripts in JTH journal
One Identified biomarkers for breakthrough stroke
In the other we developed a new CHADS-VASc-Biomarkers score!”
Read more in the University of Vermont News Release.
Title 1: Circulating biomarkers and ischemic stroke risk in adults with atrial fibrillation taking anticoagulation: the Reasons for Geographic And Racial Differences in Stroke study
Read the full article here.
Title 2: Improving stroke risk prediction in atrial fibrillation with circulating biomarkers: the CHA2DS2-VASc–Biomarkers model
Read the full article here.
Authors: Samuel A.P. Short, Erin Hald, Katherine Wilkinson, George Howard, Virginia Howard, Suzanne E. Judd, Elsayed Z. Soliman, Brett Kissela, David Robinson, Robert Stanton, Mary Cushman
The Calculator is live here.

Stay updated on all science in the field of hematology with Hemostasis Today.
-
Nov 18, 2026, 15:11Vansh Yaduvanshi: Why Compatible Blood Groups Do Not Always Mean Compatible Blood
-
Nov 18, 2026, 14:49Estetrol-Based Contraception in PCOS and Its Effects on Coagulation – RPTH Journal
-
Nov 18, 2026, 14:41Factor V Deficiency: Diagnostic Challenges and the Role of Combined Factor V and VIII Deficiency
-
Nov 18, 2026, 14:29Maxime Dely: When Patient Encounters Become Life Lessons
-
Nov 18, 2026, 14:23Basanta Khatiwada: Advancing Haematology Through Research and Innovation at HAEMATOCON 2026
-
Nov 18, 2026, 14:13Alvin Katumba: Sickle Cell Disease Research Recognised With a 2026 ASH Abstract Achievement Award
-
Nov 18, 2026, 13:34Vincenzo De Angelis: Strengthening Plasma Management and Quality Control in Eastern Europe
-
Nov 18, 2026, 13:34Standardizing Bleeding Outcome Assessment in Hemophilia Clinical Trials – JTH
-
Nov 18, 2026, 13:34Nicolas Gendron: The Ecological Transition in Thrombosis and Haemostasis